Use access key #2 to skip to page content.
$10.35 -0.45 (-4.17%)
10/10/2008 4:00 PM

Celera Group, Applera Corp. (CRA)

CAPS Rating:
***

The Company conducts business through two business segments: Applied Biosystems Group and Celera Genomics Group.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CRA

Add Stock to Watchlist

What the Community Thinks

Total Members

83 Outperforms
12 Underperforms
 

All-Stars

17 Outperforms
2 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Members bullish on CRA are also bullish on:

Members bearish on CRA are also bearish on:

Ticker Tags

Small Cap (1922), Rule Breakers Universe (161), Scientific & Technical Instruments (112), Technical Instruments (73)
Suggest a tag

Celera Group, Applera Corp. At A Glance

Current Price: $10.35
Last Trade Time: 10/10/2008 4:00 PM
Open: $10.24
Previous Close: $10.80
Daily Range: $9.60 - $11.18
52-Week Range: $10.73 - $17.56
Volume: 1,335,056
Market Cap: $867.19M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

CRA VS S&P 500 (SPY)

CRA 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for CRA

More Headlines...

Top Bull Pitch

Recs

1

Celera Group, Applera Corp. (CRA)

Avatar jclawsonPHN (27.47) Submitted: 10/16/07 11:16 AM

Cutting edge healthcare. This company is at the front lines of curing and treating disease using the human genome and cell protiens to discover the most accurate and efficient ways to treat if not cure disease. They are currently focusing a lot of attention on the cancer field because of its diverse...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 15 :   1 2 3 Next »

Recs

0

 (CRA)

Avatar bclan13 (99.58) Submitted: 8/05/08 2:29 AM : Outperform Start Price: $11.36 CRA Score: 20.30

I just see all the personalized medicine stocks as a rising tide that needs to be surfed ... i don't even see much froth here, just a really great theme that is going to work for some time

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRA)

Avatar burnishedcoppera (< 20) Submitted: 5/20/08 10:51 PM : Outperform Start Price: $12.94 CRA Score: 17.58

Curing disease at the genitic level, the research and development wave of the future. Applications are pending for FDA approval for testing of of a hormone injection for treating obesity.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRA)

Avatar ResearchLover (< 20) Submitted: 3/25/08 1:52 PM : Outperform Start Price: $14.50 CRA Score: 5.96

A celera spinoff would be good for shareholders. Wonder how CAPS would handle the virtual windfall, though? Let's find out!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRA)

Avatar NoobTrader (85.67) Submitted: 2/02/08 1:37 AM : Outperform Start Price: $13.26 CRA Score: 18.27

Genetic testing will be a big part of medical care in the future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRA)

Avatar asgeirss (< 20) Submitted: 12/19/07 7:01 PM : Outperform Start Price: $16.64 CRA Score: 1.93

Kaupa Var einu sinni í 250

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 15 :   1 2 3 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRothCapital 69.87 04/25/08 Outperform NS $13.20-21.59%-36.52%+14.93
TrackJMP 24.52 12/19/07 Outperform NS $15.72-34.16%-39.36%+5.20
TrackSoros 84.59 09/30/07 Outperform NS $14.06-26.39%-42.00%+15.61 Toggle the visibility of 60-Second Pitch and replies
TrackLeerinkSwan 88.77 12/20/06 Outperform NS $13.41-22.82%-37.81%+14.99

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners